Congo needs to do more to raise awareness about mpox and the availability of vaccines, an official with the response team ...

Interim results from a National Institutes of Health (NIH)-supported clinical trial of the Bavarian Nordic mpox vaccine ...

Bavarian Nordic’s MVA-BN vaccine showed equivalent antibody response and safety between teenagers and adults in an NIH study.

STORY: Benire Furahini Buchaguzi is at the forefront of Democratic Republic of Congo's uphill battle against mpox.The 22-year ...

Mpox cases rose in some areas, including Los Angeles, while a deadlier outbreak is affecting Africa. How should at-risk ...

The spread of mpox in congested refugee camps and prisons is raising vaccine needs as Africa struggles to contain multiple ...

(Reuters) -The World Health Organization said on Monday it had approved Bavarian Nordic's mpox vaccine for adolescents aged ...

The NIH clinical trial aims to address the knowledge gap regarding vaccine use in adolescent populations. A clinical trial ...

Kaseya said the Africa CDC needed roughly 10 million doses and $600 million to contain the outbreak, but African officials ...

Africa's top public health agency says the number of mpox-related deaths in the continent has surpassed 1,000 and warned of ...

A National Institutes of Health (NIH)-funded clinical trial of an mpox vaccine in adolescents found it was safe and generated ...

Interim results of a phase 2 trial indicate that the mpox vaccine MVA-VN has an immune response in adolescents similar to ...